New Key Statistics Module, Z-Score and F-Score
OTCPK:CLYYF Key Ratios
| Market Cap $ M | 14.96 |
| Enterprise Value $ M | 12.98 |
| P/E(ttm) | 14.50 |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.83 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | 0.02 |
| Beneish M-Score | 10.62 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 11.89 |
| EV-to-EBITDA | 9.68 |
| PEG | -- |
| Shares Outstanding M | 47.26 |
| Net Margin (%) | 3,952.38 |
| Operating Margin % | -6,400.00 |
| Pre-tax Margin (%) | 3,952.38 |
| Quick Ratio | 1.92 |
| Current Ratio | 1.92 |
| ROA % (ttm) | 12.50 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | -30.61 |
| Dividend Yield % | -- |
| Altman Z-Score | -113.23 |
CLYYF Number of Guru Trades
CLYYF Volume of Guru Trades
Gurus Latest Trades with OTCPK:CLYYF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:CLYYF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Celyad Oncology SA Insider Transactions
No Available Data
News about OTCPK:CLYYF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers